NCT00256698 Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy Status COMPLETED Phase PHASE3
NCT00256217 Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women Status COMPLETED Phase PHASE2
NCT00255645 G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study) Status TERMINATED Phase N/A
NCT00255528 Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric Subjects Status COMPLETED Phase PHASE3
NCT00255515 Seroquel® Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia Status COMPLETED Phase PHASE4
NCT00255502 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric Subjects Status COMPLETED Phase PHASE3
NCT00255489 A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer Status COMPLETED Phase PHASE1
NCT00255476 The IRESSA Novel Head and Neck Chemotherapy Evaluation Study Status COMPLETED Phase PHASE2
NCT00255281 Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation Status COMPLETED Phase PHASE2
NCT00255255 Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma Status COMPLETED Phase PHASE3
NCT00254813 Fast Titration Of Quetiapine Versus Currently Approved Titration Status COMPLETED Phase PHASE3
NCT00254800 The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females Status COMPLETED Phase PHASE1
NCT00254787 Rapid Dose Escalation of Quetiapine Versus Conventional Escalation in Acute Schizophrenic Patients Status COMPLETED Phase PHASE2
NCT00254774 Efficacy and Safety of Quetiapine Compared With Valproate in the Treatment of Patients With Bipolar Disorder and Rapid Cycling Status COMPLETED Phase PHASE3
NCT00254748 Verkes Borderline Study: The Effect of Quetiapine on Borderline Personality Disordered Patients Status COMPLETED Phase PHASE2